The UK National Institute of Clinical Excellence (NICE) have amended their prostate cancer guidelines and now recommend that the national standard for risk stratification for prostate cancer be based on the Cambridge Prognostic Groups (CPG) which was developed in the University of Cambridge Department of Surgery by Professor Vincent J Gnanapragasam and colleagues. The updated […]

The BORS meeting will be held online as a virtual conference. The call for abstracts for the Annual Meeting is now open. The deadline for submission is 31st May 2021.

‘The research paves the way for cell therapies to treat liver disease – in other words, growing ‘mini-bile ducts’ in the lab as replacement parts that can be used to restore a patient’s own liver to health – or to repair damaged organ donor livers, so that they can still be used for transplantation.’ University […]

The National Prostate Cancer Audit (NPCA) has published a short report on the use of the Cambridge-developed Cambridge Prognostic Groups for non-metastatic prostate cancer and its utility and benefit in better reporting of treatment trends and patterns in the UK. This follows on from a paper jointly published last year. The NPCA will be used […]

Mr Vikas Khanduja has been awarded a Hunterian Professorship (2021) by the Royal College of Surgeons of England and will be invited to give the annual Lecture, which will be titled:‘Evaluating the Role of Novel Technologies in Optimising Arthroscopic Management of Femoroacetabular Impingement’.

Mr Vincent Gnanapragasam has been promoted to a Personal Readership in Urology effective from the 1st of October 2020

Grant Stewart has been appointed Professor of Surgical Oncology at the University of Cambridge. CRUK article

Mr Siong Liau has been awarded the Hunterian Lectureship (2020) by the Research Committee of the Royal College of Surgeons for his lecture entitled ‘Counteracting Immune evasion in DNA repair-deficient pancreatic cancers for immunotherapy’.